7 completed, 1 not yet recruiting, 1 unknown. 9 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 7, Not yet recruiting 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Coronary Arteriosclerosis: new trials by email Literature Review of Coronary Arteriosclerosis trials Research Report on Coronary Arteriosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose, Human Recombinant Fibroblast Growth Factor-1 (FGF1-141) - high dose, Placebo - Coronary Disease, Coronary Heart Disease | Phase 2 | Not yet recruiting | Venturis Therapeutics, Inc. | 150 | 2027-09-01 | 2026-08-19 |
| Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery Aspirin - Coronary Arteriosclerosis | Phase 2 | Unknown | Centro Cardiologico Monzino | 99 | 2011-09-01 | 2011-11-08 |
| Plug Arterial Closure System (PACS, 7F) Vascular access site closure (7F Ensure) - Angioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis | Phase 2 | Completed | Cordis US Corp. | 30 | 2007-07-01 | 2012-02-28 |
| Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event prasugrel 10 mg, clopidogrel, prasugrel placebo - Coronary Arteriosclerosis, Acute Coronary Syndrome | Phase 2 | Completed | Eli Lilly and Company | 139 | 2006-07-01 | 2010-11-03 |
| Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery TP10 - Myocardial Ischemia, Coronary Arteriosclerosis | Phase 2 | Completed | Avant Immunotherapeutics | 300 | 2004-04-01 | 2007-07-20 |
| Estrogen, HDL, and Coronary Heart Disease in Women Estrogens, Conjugated (USP), Medroxyprogesterone 17-Acetate, Placebo - Cardiovascular Diseases, Coronary Disease | Phase 2 / Phase 3 | Completed | Tufts University | 309 | 2004-03-01 | 2016-04-21 |
| Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease Forearm blood flow study, Brachial artery reactivity study, Treadmill exercise test - Coronary Arteriosclerosis | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 42 | 2003-09-25 | 2017-07-02 |
| Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) dietary supplements, vitamin C, vitamin E - Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 2 | Completed | Brigham and Women's Hospital | 1993-05-01 | 2020-07-15 | |
| Lifestyle Heart Trial diet, vegetarianism, diet, fat-restricted, exercise - Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1989-04-01 | 2013-12-13 |
Coronary Artery Disease (9) · Coronary Disease (4) · Myocardial Ischemia (4) · Cardiovascular Diseases (3) · Heart Diseases (3) · Acute Coronary Syndrome (1) · Aneurysm (1) · Aortic Valve Insufficiency (1) · Atherosclerosis (1) · Hypercholesterolemia (1) · Hypertension (1) · Ischemia (1) · Mitral Valve Insufficiency (1) · Motor Activity (1) · Myocardial Infarction (1)
Arterial Occlusive Diseases (9) · Arteriosclerosis (9) · Vascular Diseases (9) · Cardiovascular Diseases (6) · Heart Diseases (6) · Coronary Disease (5) · Myocardial Ischemia (5) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Aortic Valve Disease (1) · Behavior (1) · Dyslipidemias (1) · Heart Valve Diseases (1) · Hyperlipidemias (1) · Infarction (1)
Ascorbic Acid (1) · Aspirin (1) · Clopidogrel (1) · Diet (1) · Diet, Fat-Restricted (1) · Diet, Vegetarian (1) · Dietary Supplements (1) · Estrogens, Conjugated (USP) (1) · Exercise (1) · Medroxyprogesterone Acetate (1) · Prasugrel Hydrochloride (1) · Sugars (1) · Vitamin E (1) · beta Carotene (1)
National Heart, Lung, and Blood Institute (NHLBI) (2) · Avant Immunotherapeutics (1) · Brigham and Women's Hospital (1) · Centro Cardiologico Monzino (1) · Cordis US Corp. (1) · Eli Lilly and Company (1) · Tufts University (1) · Venturis Therapeutics, Inc. (1)
United States (4) · Italy (1) · Mexico (1)
David M Herrington, MD (1) · Dean Ornish (1) · Emerson Perin, MD, PhD (1) · JoAnn Manson (1) · Jorge Luna, MD (1) · K. Gould (1) · Stefania Lamon-Fava (1)
PMID 17698683, PMID 18174456, PMID 18460663, PMID 18984888, PMID 19064521, PMID 19116389, PMID 19155011, PMID 19237716, PMID 19451353, PMID 19489872, PMID 19491213, PMID 19491386, PMID 20580029, PMID 20846599, PMID 23066166, PMID 23223867, PMID 29776960, PMID 34039021
R01HL042554 (1), R01HL046959 (1), R01HL070081 (1)